Serina Therapeutics Stock Price on September 5, 2024
| SER Stock | 4.79 0.64 15.42% |
Below is the normalized historical share price chart for Serina Therapeutics extending back to November 29, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Serina Therapeutics stands at 4.79, as last reported on the 18th of December 2024, with the highest price reaching 5.00 and the lowest price hitting 4.32 during the day.
If you're considering investing in Serina Stock, it is important to understand the factors that can impact its price. Serina Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.007, which indicates the firm had a -0.007% return per unit of risk over the last 3 months. Serina Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Serina Therapeutics' Variance of 60.13, coefficient of variation of (5,360), and insignificant Risk Adjusted Performance to confirm the risk estimate we provide.
At this time, Serina Therapeutics' Total Stockholder Equity is relatively stable compared to the past year. As of 12/18/2024, Common Stock Shares Outstanding is likely to grow to about 1.2 M, while Common Stock is likely to drop slightly above 14.2 K. . At this time, Serina Therapeutics' Price To Sales Ratio is relatively stable compared to the past year. As of 12/18/2024, Price Sales Ratio is likely to grow to 148.28, while Price Earnings Ratio is likely to drop (1.05). Serina Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of November 2018 | 200 Day MA 11.086 | 50 Day MA 8.1664 |
Serina |
Sharpe Ratio = -0.007
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SER |
Estimated Market Risk
| 7.92 actual daily | 70 70% of assets are less volatile |
Expected Return
| -0.06 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Serina Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Serina Therapeutics by adding Serina Therapeutics to a well-diversified portfolio.
Book Value (1.86) | Enterprise Value 62.8 M | Enterprise Value Ebitda 40.0756 | Price Sales 18.0288 | Shares Float 2.9 M |
Related Headline
Lipocine Headline on 5th of September 2024
Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented... by finance.yahoo.com
Lipocine Inc. , a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that a poster featuring Phase 2 data on LPCN 2401 will be presented at the Obesity Societys Annual ObesityWeek conference to be held November 3 6, 2024 in San Antonio, TX.
Serina Therapeutics Valuation on September 5, 2024
It is possible to determine the worth of Serina Therapeutics on a given historical date. On September 5, 2024 Serina was worth 7.96 at the beginning of the trading date compared to the closed value of 7.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Serina Therapeutics stock. Still, in general, we apply an absolute valuation method to find Serina Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Serina Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Serina Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 8.10 | 8.10 | 7.78 | 7.95 | 2,947 | |
09/05/2024 | 7.96 | 8.00 | 7.96 | 7.97 | 1,185 |
| 7.97 | 7.97 | 7.97 | 7.97 | 719.00 |
| Backtest Serina Therapeutics | | | Serina Therapeutics History | | | Serina Therapeutics Valuation | Previous | Next |
Serina Therapeutics Trading Date Momentum on September 5, 2024
| On September 06 2024 Serina Therapeutics was traded for 7.97 at the closing time. Highest Serina Therapeutics's price during the trading hours was 7.97 and the lowest price during the day was 7.97 . The net volume was 719. The overall trading history on the 6th of September did not result in any price rise and fall. The trading price change to current price is 13.43% . |
Serina Therapeutics Fundamentals Correlations and Trends
By evaluating Serina Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Serina Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Serina financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Serina Therapeutics Stock history
Serina Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Serina is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Serina Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Serina Therapeutics stock prices may prove useful in developing a viable investing in Serina Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.1 M | 1.2 M |
Serina Therapeutics Stock Technical Analysis
Serina Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Serina Therapeutics Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Serina Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NYSE MKT Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Serina Therapeutics December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Serina Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Serina Therapeutics shares will generate the highest return on investment. By undertsting and applying Serina Therapeutics stock market strength indicators, traders can identify Serina Therapeutics entry and exit signals to maximize returns
Serina Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Serina Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Serina Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Serina to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.1787 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.